Cargando…

Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis

High-throughput metabolite profiling provides the opportunity to reveal metabolic mechanisms and identify biomarkers. Psoriasis is an immune-mediated chronic inflammatory disease. However, the role of metabolism in psoriasis pathogenesis remains unclear. Methods: Plasma samples of individuals (45 ps...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chao, Hou, Guixue, Zeng, Chunwei, Ren, Yan, Chen, Xiang, Peng, Cong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738860/
https://www.ncbi.nlm.nih.gov/pubmed/33391503
http://dx.doi.org/10.7150/thno.51154
_version_ 1783623212028919808
author Chen, Chao
Hou, Guixue
Zeng, Chunwei
Ren, Yan
Chen, Xiang
Peng, Cong
author_facet Chen, Chao
Hou, Guixue
Zeng, Chunwei
Ren, Yan
Chen, Xiang
Peng, Cong
author_sort Chen, Chao
collection PubMed
description High-throughput metabolite profiling provides the opportunity to reveal metabolic mechanisms and identify biomarkers. Psoriasis is an immune-mediated chronic inflammatory disease. However, the role of metabolism in psoriasis pathogenesis remains unclear. Methods: Plasma samples of individuals (45 psoriasis and 45 sex‐, age-, and BMI-matched healthy controls) were collected. Non-targeted metabolomics and amino acid- or carnitine-targeted metabolomics were conducted, then, plasma samples of mice induced by imiquimod (IMQ) were subjected to the amino acid- and carnitine-targeted metabolomic profiling. Flow cytometry was used to study the effect of L-carnitine (LC(C0)) on IMQ-induced psoriatic inflammation. Results: Through the non-targeted metabolomics approach, we detected significantly altered amino acids and carnitines in psoriasis patients. Amino acid-targeted metabolomic profiling identified 37 amino acids altered in psoriasis, of these 23 were markedly upregulated, including essential amino acids (EAAs), and branched-chain amino acids (BCAAs), whereas glutamine, cysteine, and asparagine were significantly down-regulated. Carnitine-targeted metabolomic profiling identified 40 significantly altered carnitines, 14 of which included palmitoylcarnitine (C16) and were markedly downregulated in psoriasis, whereas hexanoylcarnitine (C6) and 3-OH-octadecenoylcarnitine (C18:1-OH) were significantly upregulated. Interestingly, glutamine, asparagine, and C16 levels were negatively correlated with the PASI score. Moreover, a higher abundance of LC(C0) was associated with markedly reduced IMQ-induced epidermal thickening and infiltration of Th17 cells in skin lesions, indicating LC(C0) supplementation as a potential therapy for psoriasis treatment. Conclusion: Our results suggested the metabolism of amino acids and carnitines are significantly altered in psoriasis, especially the metabolism of EAAs, BCAAs, and LC(C0), which may play key roles in the pathogenesis of psoriasis.
format Online
Article
Text
id pubmed-7738860
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-77388602021-01-01 Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis Chen, Chao Hou, Guixue Zeng, Chunwei Ren, Yan Chen, Xiang Peng, Cong Theranostics Research Paper High-throughput metabolite profiling provides the opportunity to reveal metabolic mechanisms and identify biomarkers. Psoriasis is an immune-mediated chronic inflammatory disease. However, the role of metabolism in psoriasis pathogenesis remains unclear. Methods: Plasma samples of individuals (45 psoriasis and 45 sex‐, age-, and BMI-matched healthy controls) were collected. Non-targeted metabolomics and amino acid- or carnitine-targeted metabolomics were conducted, then, plasma samples of mice induced by imiquimod (IMQ) were subjected to the amino acid- and carnitine-targeted metabolomic profiling. Flow cytometry was used to study the effect of L-carnitine (LC(C0)) on IMQ-induced psoriatic inflammation. Results: Through the non-targeted metabolomics approach, we detected significantly altered amino acids and carnitines in psoriasis patients. Amino acid-targeted metabolomic profiling identified 37 amino acids altered in psoriasis, of these 23 were markedly upregulated, including essential amino acids (EAAs), and branched-chain amino acids (BCAAs), whereas glutamine, cysteine, and asparagine were significantly down-regulated. Carnitine-targeted metabolomic profiling identified 40 significantly altered carnitines, 14 of which included palmitoylcarnitine (C16) and were markedly downregulated in psoriasis, whereas hexanoylcarnitine (C6) and 3-OH-octadecenoylcarnitine (C18:1-OH) were significantly upregulated. Interestingly, glutamine, asparagine, and C16 levels were negatively correlated with the PASI score. Moreover, a higher abundance of LC(C0) was associated with markedly reduced IMQ-induced epidermal thickening and infiltration of Th17 cells in skin lesions, indicating LC(C0) supplementation as a potential therapy for psoriasis treatment. Conclusion: Our results suggested the metabolism of amino acids and carnitines are significantly altered in psoriasis, especially the metabolism of EAAs, BCAAs, and LC(C0), which may play key roles in the pathogenesis of psoriasis. Ivyspring International Publisher 2021-01-01 /pmc/articles/PMC7738860/ /pubmed/33391503 http://dx.doi.org/10.7150/thno.51154 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Chen, Chao
Hou, Guixue
Zeng, Chunwei
Ren, Yan
Chen, Xiang
Peng, Cong
Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis
title Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis
title_full Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis
title_fullStr Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis
title_full_unstemmed Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis
title_short Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis
title_sort metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738860/
https://www.ncbi.nlm.nih.gov/pubmed/33391503
http://dx.doi.org/10.7150/thno.51154
work_keys_str_mv AT chenchao metabolomicprofilingrevealsaminoacidandcarnitinealterationsasmetabolicsignaturesinpsoriasis
AT houguixue metabolomicprofilingrevealsaminoacidandcarnitinealterationsasmetabolicsignaturesinpsoriasis
AT zengchunwei metabolomicprofilingrevealsaminoacidandcarnitinealterationsasmetabolicsignaturesinpsoriasis
AT renyan metabolomicprofilingrevealsaminoacidandcarnitinealterationsasmetabolicsignaturesinpsoriasis
AT chenxiang metabolomicprofilingrevealsaminoacidandcarnitinealterationsasmetabolicsignaturesinpsoriasis
AT pengcong metabolomicprofilingrevealsaminoacidandcarnitinealterationsasmetabolicsignaturesinpsoriasis